Tag: Biocon

Biocon is strategically pursuing in-licensing opportunities to bolster its biosimilars portfolio and drive significant margin expansion, leveraging a multi-product launch cycle and a shift towards consolidating its global commercial ...

Mumbai: Biopharma major Biocon is going full throttle on adoption of artificial intelligence and scaling up investments to embed the latest generation data science and analytical tools deeply into ...

New Delhi: Biocon Ltd on Tuesday announced the commercial launch of biosimilars Bosaya and Aukelso, indicated for different serious bone conditions, in the US.Bosaya (biosimilar to Prolia) and Aukelso ...

Indian biopharmaceutical company Biocon said on Saturday it would fully integrate its biosimilar unit Biocon Biologics as a wholly owned subsidiary.Biocon said in a statement it will acquire the ...

Biocon Ltd is exploring the merger of biosimilars arm Biocon Biologics Ltd with itself, people aware of the development told ET. The potential deal is said to value the ...

Biopharmaceutical firm Biocon plans to invest $150 million in capital expenditure over the next couple of years, with $100 million earmarked for its biologics division and the remaining for ...

Biocon Biologics, the subsidiary of Biocon on Saturday has received the USFDA nod to launch the biosimilar version of Janssen's Stelara (Ustekinumab) used for the treatment of autoimmune disorders ...

New Delhi: Biocon Ltd on Monday announced the signing of a semi-exclusive distribution and supply agreement with Mexico-based Medix for the commercialisation of its drug Liraglutide (gSaxenda), used in ...

Shivali Rajput, 43, excels in her job, earns well and overshoots her career targets year after year. But when it comes to managing her weight, Rajput’s efforts have come ...

Biocon on Monday said its Board has approved the appointment of Peter Bains as the Group CEO, with effect from today.He will be reporting directly to Biocon Group chairperson, ...